期刊文献+

慢性前列腺炎的“鸡尾酒”式疗法(附100例报告) 被引量:1

The Cocktail-theraphy for Chronic Prostatitis (Report of 100 Cases)
下载PDF
导出
摘要 目的探讨'鸡尾酒'式疗法对慢性前列腺炎(CP)的临床效果.方法 选择中、重度慢性前列腺炎(CP)患者100例,其中细菌性前列腺炎13例,非细菌性前列腺炎87例,采用'鸡尾酒'式疗法,应用抗生素、α1-受体阻滞剂、选择性环氧化酶(COX-2)抑制剂、蛋白水解酶制剂和中成药等治疗1.5~6.0个月,分析疗效.结果 100例患者随访8~18个月,行2次慢性前列腺炎症状评分(CPSI),平均(16.5±7.5)分,与治疗前的(25.0±15.0)分比较差别有显著性意义(P<0.05).治疗前、后WBC均值间差别有显著性意义(P<0.05).治疗期和随访期疗效间差别无显著性意义(P>0.05).结论 适宜的抗生素,α1-受体阻滞剂,选择性COX-2抑制剂,蛋白水解酶制剂和中药等'鸡尾酒'式疗法对慢性前列腺炎有较好疗效. Objective To study the clinical effect of cocktail - theraphy on chronic prostatitis (CP). Methods 100 CP cases were selected including 12 germ CP and 88 no - germ CP, we treated CP for 1.5 -6 months with the cocktail - theraphy namely α-adrenoceptor blocker combined with antibiotics, cycllooxygenase -2 inhibitor, proteinase and chinese patient medicines, its effects was evaluated by the chronic prostatitis symptom index ( CPSI), examination prostate secretion (EPS) and germ examination. Results The CPSI score of the treated group decreased from 33.4 to 13.4, the number of WBC from 33.4/HP to 12.8/HP, was significant difference with pretreatment after following 10. 3 months. After treatment, germ culture is negative in 9/12 (70. 1% ) germ CP by PPMT. According to CPSI, there were 20.5% curative rate, 47.0% significant effective rate, 18.5% effective rate, 14. 0% no effective rate. Conclusion The cocktail - theraphy with α1-adrenoceptor blocker combined with antibiotics, cycllooxygenase-2 inhibitor, proteinase and Chinese herb, is good effective to CP.
作者 尹宗立
出处 《中国全科医学》 CAS CSCD 2005年第16期1357-1358,共2页 Chinese General Practice
关键词 前列腺炎 慢性 “鸡尾酒”式疗法 Prostatitis, chronic Cocktail - theraphy
  • 相关文献

参考文献9

二级参考文献83

  • 1Cheah PY, Liong ML, Krieger JN. Terazesin therapy for CP/CPPS :randomized placebo control trial. J Urol,2003 ,169 :592-596. 被引量:1
  • 2Kaplan SA,Jacob BZ. Urodynamic evidence of vesical neck obstruction in men misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol,1994,152:2663-2665. 被引量:1
  • 3Pontari MA. Inflammation and anti-inflammatory therapy in chronic prostatitis. Urology ,2002,606A :29-33. 被引量:1
  • 4Shahed AR, Shoskes DA. Correlation of β-endorphin and prostaglandin E2 level in prostatic fluid with chronic prostatitis with diagnosis and treatment response. J Urol,2001,166 : 1738-1741. 被引量:1
  • 5Shoskes DA, Thomas K, Cook D, et al. Cytokine polymorphism in men with CP/CPPS: association with diagnosis and treatment response. J Urol,2002,168:331. 被引量:1
  • 6Palapatta GS, Shoskes DA. Resolution of the CPPS after renal transplation. J Urol,2000,164 : 127. 被引量:1
  • 7Dimitrakov JD, Dikov DY, Lagny-sur-marine cedex. Mycophenolate mofetil in the treatment of CPPS. A double-blind placebo-controlled study. J Urol,2003, AUA Suppl, 112. 被引量:1
  • 8Harris SG, Padilla J, Phipps RP, et al. Prostaglandins as modulators of immunity. Trends in Immunology ,2002,23 : 144-150. 被引量:1
  • 9Schaffer AJ. Advances in the diagnosis and treatment of prostatitis.Urology, 2002,606 A. 被引量:1
  • 10Schaffer A J, Krieger JN, Curtis N, et al. Overview summary statement. Urology ,2002,606A : 1-4. 被引量:1

共引文献166

同被引文献8

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部